IP
Therapeutic Areas
Arsenal Biosciences Pipeline
| Drug | Indication | Phase |
|---|---|---|
| AB-3028 | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | IND-Enabling |
| AB-7000 | Undisclosed Solid Tumor | IND-Enabling |
| AB-4000 Series (with BMS) | Solid Tumors | Discovery/Preclinical |